Pancreatic Cancer Research

ResearcherCold Spring Harbor LaboratoryActive in the last 2 years

Iok In Christine Chio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3635-2679; OpenAlex author ID A5072873302. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
53
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 11

  1. eIF4G2-Dependent Translation Restrains Pancreatic Cancer Progression. Last author DOI 10.1158/0008-5472.can-25-4299↗
  2. Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO. Co-author DOI 10.1016/j.crmeth.2024.100760↗
  3. A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0740↗
  4. Discovery and Evaluation of C6-Substituted Pyrazolopyrimidine-Based Bisphosphonate Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase and Evaluation… Co-author DOI 10.1021/acs.jmedchem.3c01271↗
  5. Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Last author DOI 10.1016/j.molcel.2022.06.005↗
  6. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41467-019-13086-5↗
  7. Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-1398↗
  8. Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies. First author DOI 10.3390/genes11010006↗
  9. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Co-author DOI 10.1084/jem.20162024↗
  10. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer. Co-author DOI 10.1016/j.cell.2016.06.056↗
  11. Organoid models of human and mouse ductal pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.12.021↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marina Ayres Pereira · 2 shared papers, 2019–2024 · strength 0.42
  2. Karina M. Chan · 2 shared papers, 2019–2024 · strength 0.29
  3. Álvaro Curiel‐García · 1 shared paper, 2026 · strength 0.28
  4. James M. Powers · 1 shared paper, 2026 · strength 0.28
  5. Alison B. Ross · 1 shared paper, 2024 · strength 0.22
  6. Olca Baştürk · 2 shared papers, 2015–2024 · strength 0.20
  7. Mariano Ponz‐Sarvisé · 4 shared papers, 2015–2019 · strength 0.20
  8. Youngkyu Park · 4 shared papers, 2015–2019 · strength 0.20
  9. David Arthur Tuveson · 4 shared papers, 2015–2019 · strength 0.20
  10. Hervé Tiriac · 4 shared papers, 2015–2019 · strength 0.20
  11. Daniel Öhlund · 4 shared papers, 2015–2019 · strength 0.20
  12. Craig J. Thomas · 2 shared papers, 2019–2022 · strength 0.19
  13. Rebecca Boutin · 1 shared paper, 2023 · strength 0.17
  14. Youla S. Tsantrizos · 1 shared paper, 2023 · strength 0.17
  15. Olivera Grbovic-Huezo · 1 shared paper, 2024 · strength 0.17
  16. Tuomas Tammela · 1 shared paper, 2024 · strength 0.17
  17. Anupriya Singhal · 1 shared paper, 2024 · strength 0.17
  18. Rona D. Yaeger · 1 shared paper, 2024 · strength 0.17
  19. Lindsey A. Baker · 3 shared papers, 2015–2019 · strength 0.15
  20. Vincenzo Corbo · 3 shared papers, 2015–2019 · strength 0.15
  21. Tobiloba E. Oni · 3 shared papers, 2015–2019 · strength 0.15
  22. Chang‐Il Hwang · 3 shared papers, 2015–2019 · strength 0.15
  23. Dannielle D. Engle · 3 shared papers, 2015–2019 · strength 0.15
  24. Dan He · 1 shared paper, 2022 · strength 0.12
  25. Michael D. Kluger · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.